Mcrb earnings
Web5 feb. 2024 · Meeko Media/iStock via Getty Images. Investors who follow my biotech musings might be becoming tired of my “dog-with-a-bone” coverage of Seres Therapeutics (NASDAQ:MCRB).I find it curious being almost the only Seeking Alpha author writing about this stock, but I think the evolving story might be of some interest to investors seeking to … Web10 apr. 2024 · From the analysts’ viewpoint, the consensus estimate for the company’s annual revenue in 2024 is $131.81 million. The company’s revenue is forecast to grow by 1,749.20% over what it did in 2024. A company’s earnings reviews provide a brief indication of a stock’s direction in the short term, where in the case of Seres Therapeutics Inc.
Mcrb earnings
Did you know?
Web14 apr. 2024 · Seres Therapeutics (MCRB) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the ... Web7 uur geleden · U.S. stock indexes were set for a lower open on Friday as weak March retail sales data suggested the economy was losing steam, while upbeat earnings from a trio of big banks helped assuage fears ...
Web11 apr. 2024 · What's Happening With MCRB Stock Today? Seres Therapeutics Inc (MCRB) stock is trading at $5.85 as of 1:15 PM on Tuesday, Apr 11, an increase of … Web30 mrt. 2024 · Learn more about Seres Therapeutics's (MCRB) upcoming earnings announcement. Get Earnings Calendar and Data from Zacks.com What date does …
Web7 mrt. 2024 · Q4 2024 Seres Therapeutics, Inc. Earnings Conference Call. Mar 7, 2024 at 8:30 AM EST Click Here for Webcast. Recent Presentation Corporate Presentation 1.8 … Web7 mrt. 2024 · Seres Therapeutics (MCRB) came out with a quarterly loss of $0.54 per share versus the Zacks Consensus Estimate of a loss of $0.41. This compares to loss of $0.55 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -31.71%.
Web10 feb. 2024 · Seres Therapeutics, Inc. (MCRB) consensus earnings estimates: forecast for revenue and EPS, high & low, YoY growth, forward PE and number of analysts.
WebSeres Therapeutics Inc. balance sheet, income statement, cash flow, earnings & estimates, ratio and margins. View MCRB financial statements in full. business sales tax nyWeb11 apr. 2024 · According to the issued ratings of 5 analysts in the last year, the consensus rating for Seres Therapeutics stock is Buy based on the current 5 buy ratings for MCRB. The average twelve-month price prediction for Seres Therapeutics is $16.25 with a high price target of $25.00 and a low price target of $12.00. Learn more on MCRB's analyst … business saver swissWebMCRB earnings history information, presented by NextEarningsDate.com. Period Earnings Date GAAP; Q2 2024: 8/3/2024-0.700: Q1 2024: 5/4/2024-0.610: Q4 2024 business sa networkingWeb20 mrt. 2024 · NASDAQ:MCRB Seres Therapeutics Stock Earnings Report Current P/E ratio: -7.68 Price (Mar 20, 2024, EOD): $5.49 (Find current average P/E ratios for all … business sample paperWeb1 dag geleden · The company reported -$0.51 earnings per share for the quarter, missing the consensus estimate of -$0.455 by -$0.055. Is Seres Therapeutics overvalued? … business sapWebSeres Therapeutics (MCRB) Moves 10.9% Higher: Will This Strength Last? Seres Therapeutics (MCRB) saw its shares surge in the last session with trading volume being higher than average. business satchel bagsWeb14 apr. 2024 · The average trading volume of MCRB on April 14, 2024 was 1.05M shares. MCRB) stock’s latest price update Seres Therapeutics In. compared to its average ratio … business san antonio tx